Vaxart Submits Proxy Statement for Reverse Stock Split to Support Resumption of Trading on Nasdaq

Stock Information for TRACON Pharmaceuticals Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About TRACON Pharmaceuticals Inc.

Vaxart to Present at the H.C. Wainwright Global Investment Conference on September 8, 2025
Vaxart Announces Retirement of Chairman Michael J. Finney, Ph.D. from the Board of Directors
Concerned Vaxart Stockholders Urge Fellow Stockholders to Vote "AGAINST" Reverse Stock Split and Demand Board Accountability
Vaxart Granted Extension by Nasdaq to Regain Compliance
Concerned Vaxart Stockholders Unite to Oppose Vaxart's Latest Reverse Stock Split and Defend Stockholder Rights
Vaxart to Host Virtual Stockholder Fireside Chat on Wednesday, August 20 to Discuss Reverse Stock Split Proposal
Vaxart Provides Business Update and Reports Second Quarter 2025 Financial Results
Vaxart CEO Issues Letter to Stockholders

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.